NNovo Nordisk Read More Novo Nordisk ziltivekimab heart drug fails phase 3 trial2026-08-04 Novo Nordisk announced Friday that its experimental heart drug ziltivekimab failed to reduce major adverse cardiovascular events in…
NNovo Nordisk Read More CagriSema Setback Tests Novo Nordisk Obesity Ambitions And Growth Story2026-02-25 Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
NNovo Nordisk Read More CagriSema Setback Tests Novo Nordisk Obesity Ambitions And Growth Story2026-02-24 Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…